Primary chemotherapy versus primary surgery for ovarian cancer.
| Data(s) |
28/11/2015
|
|---|---|
| Formato |
application/pdf |
| Identificador |
http://boris.unibe.ch/78631/1/1-s2.0-S014067361501051X-main.pdf Gasparri, Maria Luisa; Panici, Pierluigi Benedetti; Papadia, Andrea (2015). Primary chemotherapy versus primary surgery for ovarian cancer. Lancet, 386(10009), pp. 2142-2143. Elsevier 10.1016/S0140-6736(15)01051-X <http://dx.doi.org/10.1016/S0140-6736(15)01051-X> doi:10.7892/boris.78631 info:doi:10.1016/S0140-6736(15)01051-X info:pmid:26638961 urn:issn:0140-6736 |
| Idioma(s) |
eng |
| Publicador |
Elsevier |
| Relação |
http://boris.unibe.ch/78631/ |
| Direitos |
info:eu-repo/semantics/restrictedAccess |
| Fonte |
Gasparri, Maria Luisa; Panici, Pierluigi Benedetti; Papadia, Andrea (2015). Primary chemotherapy versus primary surgery for ovarian cancer. Lancet, 386(10009), pp. 2142-2143. Elsevier 10.1016/S0140-6736(15)01051-X <http://dx.doi.org/10.1016/S0140-6736(15)01051-X> |
| Palavras-Chave | #610 Medicine & health |
| Tipo |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion PeerReviewed |
